Evidence map›Paper›PMID 17277362›Full record

ArticleGenetics2007

Brc1-mediated rescue of Smc5/6 deficiency: requirement for multiple nucleases and a novel Rad18 function.

Karen M Lee, Suzanne Nizza, Thomas Hayes, Kirstin L Bass, Anja Irmisch, Johanne M Murray, Matthew J O'Connell

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Karen M LeeDepartment of Oncological Sciences, Mount Sinai School of Medicine, New York, New York 10029, USA.
Suzanne Nizza
Thomas Hayes
Kirstin L Bass
Anja Irmisch
Johanne M Murray
Matthew J O'Connell
Icahn School of Medicine at Mount Sinai · USUniversity of Sussex · GB

Funding

TRAINING PROGRAM IN CANCER THERAPYT32CA078207 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI James J Manfredi · 1999 to 2026
$11.6M
Chk1 signaling in the G2 DNA damage checkpointR01CA100076 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI O'CONNELL, MATTHEW J · 2003 to 2007
$1.7M
Chk1 signaling in the G2 DNA damage checkpointR56CA100076 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI O'CONNELL, MATTHEW J · 2009 to 2009
$336k
Biotechnology and Biological Sciences Research Council BB/C510291/1NCI NIH HHS CA100076NCI NIH HHS R01 CA100076NCI NIH HHS R56 CA100076NCI NIH HHS T32 CA078207NCI NIH HHS T32 CA78207
6 · The paper itself

Abstract

Smc5/6 is a structural maintenance of chromosomes complex, related to the cohesin and condensin complexes. Recent studies implicate Smc5/6 as being essential for homologous recombination. Each gene is essential, but hypomorphic alleles are defective in the repair of a diverse array of lesions. A particular allele of smc6 (smc6-74) is suppressed by overexpression of Brc1, a six-BRCT domain protein that is required for DNA repair during S-phase. This suppression requires the postreplication repair (PRR) protein Rhp18 and the structure-specific endonucleases Slx1/4 and Mus81/Eme1. However, we show here that the contribution of Rhp18 is via a novel pathway that is independent of PCNA ubiquitination and PRR. Moreover, we identify Exo1 as an additional nuclease required for Brc1-mediated suppression of smc6-74, independent of mismatch repair. Further, the Apn2 endonuclease is required for the viability of smc6 mutants without extrinsic DNA damage, although this is not due to a defect in base excision repair. Several nucleotide excision repair genes are similarly shown to ensure viability of smc6 mutants. The requirement for excision factors for the viability of smc6 mutants is consistent with an inability to respond to spontaneous lesions by Smc5/6-dependent recombination.

Indexed as

Base SequenceCell Cycle ProteinsChromosomal Proteins, Non-HistoneDNA-(Apurinic or Apyrimidinic Site) LyaseDNA, FungalDNA RepairExodeoxyribonucleasesGenes, FungalMutationRecombination, GeneticSchizosaccharomycesSchizosaccharomyces pombe ProteinsApn2 protein, S pombeBrc1 protein, S pombeCell Cycle ProteinsChromosomal Proteins, Non-HistoneDNA-(Apurinic or Apyrimidinic Site) LyaseDNA, Fungalexodeoxyribonuclease IExodeoxyribonucleasesSchizosaccharomyces pombe ProteinsSmc5 protein, S pombesmc6 protein, S pombe

Identifiers

PMID17277362
PMCPMC1855136
OpenAlexW2137544621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.